Walgreens shoes alliance today
Walgreens Shoe Alliance
As of 10/01/2025 at 04:00 PM ET
- 52 week range
- $8.08
▼
$24.93
- Dividend yield
- 8.50%
- Price target
- $12.58
Charts, sell-side activity and rebound forecasts for Walgreens Boots Alliance Nasdaq: WBA Stocks are tracking a recovery that will likely begin this year. Trading at just 6 times earnings, this deep, high-yield value has headwinds to weather and hurdles to overcome, but there’s nowhere to go but up for its share price.
Details from 2024 include slower growth, warnings and store closure plans that have impacted the near-term outlook but improved the long-term outlook. The closing of stores and curtailment of other stressed assets is not surprising; Management made the decision when they decided, and it was the smart thing to do. The effect is that the consensus forecast is for profits to contract to their lowest levels this year, flatten in 2026, and then return to growth soon after.
Increased volume shows strong buying in Walgreens stock
Technical action is important because of chart patterns and, more importantly, trading volume. Volume indicates market interest and strength and increased significantly in the summer of 2023 and again in the summer of 2024. The increase in volume in the summer of 2024 corresponds to a sharp gap down caused by bad news, indicating market capitulation by retail traders who were met with With an influx of capital from the sell side.
Sellers, including insiders, institutions and analysts, are showing strong support and providing a price tailwind and market catalyst. Insiders own only a small portion of shares but have not sold any shares since Q1 2024. The latest activity is buying by two directors and the CFO, which is consistent with institutional activity. Institutional activity is bullish, with the balance buying for four straight quarters in 2024. Collectively, these institutions own nearly 70%, and broad-based ownership provides a solid foundation of support and strong tailwinds.
The catalyst is analyst sentiment. The consensus reported by MarketBeat fell to the limit in late 2024, but the bias was to the upside. There is a possibility that the upgrade cycle will begin later in 2025. The sentiment bias is to the upside as only four ratings are at sell, and about 26% of the 15 are tracked, while 60% are hold and 13% are buys. Likewise, the target price range indicates that this stock is trading near its bottom with a 35% gain potential according to consensus.
Walgreens will make big changes in 2025
Walgreens is on track to make big changes in 2025, and one possibility is to sell itself. News from late 2024 includes rumors of a debt-financed bid that has yet to materialize. The opportunity for investors is the premium associated with the offer, whatever it may be, and its impact on price action. However, there is a risk because industry insiders cast doubt and do not expect the deal to close. The question is what Walgreens will do next, which the private equity firm is likely to do: sell Boots and focus on its core US retail and healthcare businesses. shoes Revenue in Q4 It was only 15% of net revenue, which is not a huge loss, and is a drag on net growth, so there is a benefit.
Earnings are unlikely to change. The company has already reduced its distribution, which helped the drawdown in early 2024, and could sustain itself at the current level with or without Boots in the mix. With Boots in the portfolio, the payout ratio comes to approximately 65% of 2025 and 2024 earnings forecasts. This will change with Boots exiting the portfolio, but the balance sheet will be injected with capital to offset the increase until earnings growth resumes.
Walgreens Boots Alliance Double Bottom
The Walgreens chart shows a bottom formed in 2024, starting with the June surrender. This was followed by two tests of support, which confirmed the same level, and a subsequent rise to a higher support level later in the year. Action in 2025 matches support at the new upper level and is set to move higher.
Before you consider Walgreens Boots Alliance, you’ll need to hear this.
MarketBeat tracks the highest-rated and best-performing research analysts on Wall Street and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches up…and Walgreens Boots Alliance wasn’t on the list.
While Walgreens Boots Alliance currently has a “Reduce” rating among analysts, the top-rated analysts believe these five stocks are better buys.
View the five stocks here
If a company’s CEO, COO, and CFO were all selling shares of their stock, would you want to know?
